Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty-one research firms that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have given a buy rating to the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $610.19.
Several research analysts have commented on the company. Raymond James lifted their price target on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Citigroup lifted their price target on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. JPMorgan Chase & Co. lifted their price objective on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. BTIG Research lifted their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. Finally, Wells Fargo & Company lifted their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a report on Friday, January 24th.
View Our Latest Report on ISRG
Intuitive Surgical Stock Performance
Insider Transactions at Intuitive Surgical
In other news, EVP Robert Desantis sold 11,545 shares of the business’s stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the sale, the executive vice president now owns 5,224 shares in the company, valued at $2,607,925.28. The trade was a 68.85 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Brian Edward Miller sold 8,900 shares of the company’s stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the sale, the executive vice president now owns 5,758 shares of the company’s stock, valued at $2,793,033.06. This represents a 60.72 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 33,754 shares of company stock worth $17,691,621 over the last 90 days. 0.90% of the stock is owned by insiders.
Institutional Investors Weigh In On Intuitive Surgical
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. M.E. Allison & CO. Inc. bought a new stake in shares of Intuitive Surgical in the fourth quarter worth about $449,000. Seilern Investment Management Ltd bought a new stake in shares of Intuitive Surgical in the fourth quarter worth about $82,517,000. Sycomore Asset Management increased its holdings in shares of Intuitive Surgical by 27.4% in the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after acquiring an additional 4,079 shares in the last quarter. Exome Asset Management LLC boosted its position in shares of Intuitive Surgical by 16.8% during the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after buying an additional 1,069 shares during the period. Finally, China Universal Asset Management Co. Ltd. boosted its position in shares of Intuitive Surgical by 5.6% during the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after buying an additional 525 shares during the period. Institutional investors own 83.64% of the company’s stock.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also
- Five stocks we like better than Intuitive Surgical
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Can TikTok Stock Picks Really Make You Rich?
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- The “Quality” Rotation: Back to Basics Investing
- ETF Screener: Uses and Step-by-Step Guide
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.